Laboratorios Farmaceuticos ROVI SA
MAD:ROVI

Watchlist Manager
Laboratorios Farmaceuticos ROVI SA Logo
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Watchlist
Price: 63 EUR 1.86% Market Closed
Market Cap: 3.2B EUR
Have any thoughts about
Laboratorios Farmaceuticos ROVI SA?
Write Note

Wall Street
Price Targets

ROVI Price Targets Summary
Laboratorios Farmaceuticos ROVI SA

Wall Street analysts forecast ROVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ROVI is 96.27 EUR with a low forecast of 86.25 EUR and a high forecast of 109.2 EUR.

Lowest
Price Target
86.25 EUR
37% Upside
Average
Price Target
96.27 EUR
53% Upside
Highest
Price Target
109.2 EUR
73% Upside
Laboratorios Farmaceuticos ROVI SA Competitors:
Price Targets
AUROPHARMA
Aurobindo Pharma Ltd
28% Upside
FAE
Faes Farma SA
16% Upside
4528
Ono Pharmaceutical Co Ltd
25% Upside
PBH
Prestige Consumer Healthcare Inc
6% Upside
SOLARA
Solara Active Pharma Sciences Ltd
28% Downside
VY4
SNDL Inc
76% Upside
MEDCL
Medincell SA
28% Upside
4746
Formosa Laboratories Inc
63% Upside

Revenue
Forecast

Revenue Estimate
Laboratorios Farmaceuticos ROVI SA

For the last 8 years the compound annual growth rate for Laboratorios Farmaceuticos ROVI SA's revenue is 16%. The projected CAGR for the next 3 years is 9%.

16%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Laboratorios Farmaceuticos ROVI SA

For the last 8 years the compound annual growth rate for Laboratorios Farmaceuticos ROVI SA's operating income is 33%. The projected CAGR for the next 3 years is 17%.

33%
Past Growth
17%
Estimated Growth
Estimates Accuracy
10%
Average Beat

Net Income
Forecast

Net Income Estimate
Laboratorios Farmaceuticos ROVI SA

For the last 8 years the compound annual growth rate for Laboratorios Farmaceuticos ROVI SA's net income is 31%. The projected CAGR for the next 3 years is 16%.

31%
Past Growth
16%
Estimated Growth
Estimates Accuracy
10%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ROVI's stock price target?
Price Target
96.27 EUR

According to Wall Street analysts, the average 1-year price target for ROVI is 96.27 EUR with a low forecast of 86.25 EUR and a high forecast of 109.2 EUR.

What is Laboratorios Farmaceuticos ROVI SA's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Laboratorios Farmaceuticos ROVI SA's revenue is 16%. The projected CAGR for the next 3 years is 9%.

What is Laboratorios Farmaceuticos ROVI SA's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Laboratorios Farmaceuticos ROVI SA's operating income is 33%. The projected CAGR for the next 3 years is 17%.

What is Laboratorios Farmaceuticos ROVI SA's Net Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Laboratorios Farmaceuticos ROVI SA's net income is 31%. The projected CAGR for the next 3 years is 16%.

Back to Top